|
API5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.93400000000033E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.594100E-04 |
| Normal-vs-Stage2 |
9.020200E-04 |
| Normal-vs-Stage3 |
1.196200E-04 |
| Normal-vs-Stage4 |
6.236100E-04 |
| Stage1-vs-Stage2 |
3.373400E-01 |
| Stage1-vs-Stage3 |
3.004000E-01 |
| Stage1-vs-Stage4 |
5.182200E-01 |
| Stage2-vs-Stage3 |
8.544400E-01 |
| Stage2-vs-Stage4 |
7.820600E-01 |
| Stage3-vs-Stage4 |
8.911000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.91500000000478E-05 |
| Normal-vs-AfricanAmerican |
1.794980E-01 |
| Normal-vs-Asian |
1.302010E-03 |
| Caucasian-vs-AfricanAmerican |
1.919430E-01 |
| Caucasian-vs-Asian |
8.766600E-01 |
| AfricanAmerican-vs-Asian |
2.079400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00669999999415E-05 |
| Normal-vs-Female |
3.008800E-04 |
| Male-vs-Female |
3.074800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.819100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.94770000000655E-05 |
| Normal-vs-Age(61-80Yrs) |
2.763000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.417500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.898830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.362600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.252200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.823600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.251000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.733200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.033000E-01 |
| Classical-VS-Follicular |
1.557880E-03 |
| Classical-VS-Other |
1.013770E-01 |
| Classical-VS-Normal |
2.801900E-03 |
| Tall-VS-Follicular |
1.866160E-01 |
| Tall-VS-Other |
1.673960E-01 |
| Tall-VS-Normal |
1.074190E-02 |
| Follicular-VS-Other |
6.461400E-01 |
| Follicular-VS-Normal |
1.86896999999631E-05 |
| Other-VS-Normal |
6.262300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09719999999525E-05 |
| Normal-vs-N1 |
9.91799999999765E-05 |
| N0-vs-N1 |
5.884000E-01 |
|
|
